Enrolling
A Study to Measure Calorie Consumption and Usage in Participants With Obesity Using LY3437943
J1I-MC-GZBW - ClinicalTrials.gov - NCT06313528
The main purpose of the study is to look at the effect of the study drug compared to placebo on calorie intake, energy metabolism, and appetite.
Enter your city or zip code to find the nearest site
Trial Summary
Age Range
18 - 60 yearsConditions the trial is for
ObesityWhat the trial is testing?
retatrutideCould I receive a Placebo?
YesEnrollment Goal
74Trial Dates
Mar 20, 2024 - Aug 2025How long will I be in the trial?
The study will last up to 6 months and may include up to 20 visits.Trial Phase
IKey Requirements
Clinical trials have inclusion and exclusion requirements to determine which individuals qualify for participation. Listed below are key requirements for this clinical trial, but there may be additional requirements to qualify.Participants Must:
Have obesity or overweight
Have tried and failed at least one weight loss diet
Participants Must Not:
Have Type 1 or Type 2 Diabetes
Have change in body weight of greater than 5 kg (11 pounds) within 3 months prior to start of study
Have acute or chronic liver disease
Lilly Trial Alerts
Sign up to receive updates about new trials and find out when a clinical trial site near you starts enrolling.
Clinical Trial Resources
You will complete the questionnaire on another website.YesNo